Artículos por temáticas

The role of microRNA-485 in neurodegenerative diseases

Ryu IS, Kim DH, Cho HJ, Ryu JH.

Rev Neurosci. 2022 Jul 7;34(1):49-62. doi: 10.1515/revneuro-2022-0039. Print 2023 Jan 27.

Immunosenescence of brain accelerates Alzheimer's disease progression

Chen HY, Zhao Y, Xie YZ.

Rev Neurosci. 2022 Jul 6;34(1):85-101. doi: 10.1515/revneuro-2022-0021. Print 2023 Jan 27.

Dysfunctional microglia and tau pathology in Alzheimer's disease

Ayyubova G.

Rev Neurosci. 2022 Oct 28;34(4):443-458. doi: 10.1515/revneuro-2022-0087. Print 2023 Jun 27.

Sex Differences in Alzheimer's Disease: Insights From the Multiomics Landscape

Guo L, Zhong MB, Zhang L, Zhang B, Cai D.

Biol Psychiatry. 2022 Jan 1;91(1):61-71. doi: 10.1016/j.biopsych.2021.02.968. Epub 2021 Mar 2.

Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease

Bello-Medina PC, González-Franco DA, Vargas-Rodríguez I, Díaz-Cintra S.

Neurologia (Engl Ed). 2022 Oct;37(8):682-690. doi: 10.1016/j.nrleng.2019.06.008. Epub 2021 Sep 9.

Impact of arterial hypertension and its management strategies on cognitive function and dementia: a comprehensive umbrella review

Antonazzo B, Marano G, Romagnoli E, Ronzoni S, Frati G, Sani G, Janiri L, Mazza M.

Minerva Cardiol Angiol. 2022 Jun;70(3):285-297. doi: 10.23736/S2724-5683.20.05452-3. Epub 2020 Dec 1.

Alzheimer's disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role?

Arrona Cardoza P, Spillane MB, Morales Marroquin E.

Nutr Rev. 2022 Jan 10;80(2):271-281. doi: 10.1093/nutrit/nuab022.

Dysbiosis and Alzheimer's Disease: Cause or Treatment Opportunity?

Janeiro MH, Ramírez MJ, Solas M.

Cell Mol Neurobiol. 2022 Mar;42(2):377-387. doi: 10.1007/s10571-020-01024-9. Epub 2021 Jan 5.

Exosomal and vesicle-free tau seeds-propagation and convergence in endolysosomal permeabilization

Polanco JC, Götz J.

FEBS J. 2022 Nov;289(22):6891-6907. doi: 10.1111/febs.16055. Epub 2021 Jun 21.

Is resveratrol a prospective therapeutic strategy in the co-association of glucose metabolism disorders and neurodegenerative diseases?

Ribeiro R, Santos AC, Calazans MO, De Oliveira ACP, Vieira LB.

Nutr Neurosci. 2022 Nov;25(11):2442-2457. doi: 10.1080/1028415X.2021.1972514. Epub 2021 Sep 11.

Mild to moderate decrease in eGFR and cognitive decline in older adults

Grasing M, Kennedy K, Sarnak MJ, Burns JM, Gupta A.

Nephrol Dial Transplant. 2022 Jul 26;37(8):1499-1506. doi: 10.1093/ndt/gfab226.

Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities

Orad RI, Shiner T.

J Neurol. 2022 Feb;269(2):639-653. doi: 10.1007/s00415-021-10402-2. Epub 2021 Jan 29.

Potential neurobiological links between social isolation and Alzheimer's disease risk

Drinkwater E, Davies C, Spires-Jones TL.

Eur J Neurosci. 2022 Nov;56(9):5397-5412. doi: 10.1111/ejn.15373. Epub 2021 Jul 8.

A critical appraisal of tau-targeting therapies for primary and secondary tauopathies

Imbimbo BP, Ippati S, Watling M, Balducci C.

Alzheimers Dement. 2022 May;18(5):1008-1037. doi: 10.1002/alz.12453. Epub 2021 Sep 17.

Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression

Tok S, Ahnaou A, Drinkenburg W.

J Alzheimers Dis. 2022;88(3):809-836. doi: 10.3233/JAD-210397.